Dimensional Fund Advisors
TSHA icon

Dimensional Fund Advisors’s Taysha Gene Therapies TSHA Stock Holding History

Dimensional Fund Advisors’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16M Sell
464,771
-25,701
-5% -$152K ﹤0.01% 2631
2026
Q1 		$2.18M Hold
490,472
– – ﹤0.01% 2675
2025
Q4 		$2.7M Buy
490,472
+145,309
+42% +$706K ﹤0.01% 2674
2025
Q3 		$1.13M Buy
+345,163
New +$977K ﹤0.01% 2874

Other funds holding TSHA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors's TSHA Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its Taysha Gene Therapies (TSHA) stake by 5.2% in Q2 2026, selling an estimated $152K and leaving 464,771 shares worth $3.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2631.

Dimensional Fund Advisors first reported a position in TSHA in Q3 2025 and has held it in 4 quarters since. 209 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Dimensional Fund Advisors held 464,771 shares of Taysha Gene Therapies worth $3.16M as of Q2 2026.
  • Dimensional Fund Advisors sold 25,701 Taysha Gene Therapies shares in Q2 2026, an estimated $152K.
  • Taysha Gene Therapies made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2631 holding.
  • Dimensional Fund Advisors first reported a position in Taysha Gene Therapies in Q3 2025 and has held it in 4 quarters since.
  • 209 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.